Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G; ESC Committee for Practice Guidelines (CPG).

Eur Heart J. 2009 Oct;30(20):2493-537. doi: 10.1093/eurheartj/ehp297. Epub 2009 Aug 27. No abstract available. Erratum in: Eur Heart J. 2011 Apr;32(8):926.

2.

Echocardiographic evaluation of right heart function and pulmonary vascular bed.

Cacciapuoti F.

Int J Cardiovasc Imaging. 2009 Oct;25(7):689-97. doi: 10.1007/s10554-009-9478-6. Epub 2009 Jul 26. Review.

PMID:
19634000
3.

Updated clinical classification of pulmonary hypertension.

Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R.

J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-54. doi: 10.1016/j.jacc.2009.04.012. Review.

4.

Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, Corretti MC, Hassoun PM.

Am J Respir Crit Care Med. 2009 Apr 1;179(7):615-21. doi: 10.1164/rccm.200811-1691OC. Epub 2009 Jan 22.

5.

Intraclass correlations: uses in assessing rater reliability.

Shrout PE, Fleiss JL.

Psychol Bull. 1979 Mar;86(2):420-8. Review.

PMID:
18839484
6.

Prognostic importance of quantitative echocardiographic evaluation in patients suspected of first non-massive pulmonary embolism.

Kjaergaard J, Schaadt BK, Lund JO, Hassager C.

Eur J Echocardiogr. 2009 Jan;10(1):89-95. doi: 10.1093/ejechocard/jen169. Epub 2008 May 25.

7.

Usefulness of right ventricular isovolumic relaxation time in predicting systolic pulmonary artery pressure.

Bréchot N, Gambotti L, Lafitte S, Roudaut R.

Eur J Echocardiogr. 2008 Jul;9(4):547-54. doi: 10.1093/ejechocard/jen121. Epub 2008 Mar 14.

8.

Effects of age and pulmonary arterial hypertension on the different phases of right atrial function.

Willens HJ, Fertel DP, Qin J, Labrador E, Lowery MH.

Int J Cardiovasc Imaging. 2008 Oct;24(7):703-10. doi: 10.1007/s10554-008-9306-4. Epub 2008 May 3.

PMID:
18454278
9.

Extension of Doppler-derived echocardiographic measures of pulmonary vascular resistance to patients with moderate or severe pulmonary vascular disease.

Vlahos AP, Feinstein JA, Schiller NB, Silverman NH.

J Am Soc Echocardiogr. 2008 Jun;21(6):711-4. doi: 10.1016/j.echo.2007.10.004. Epub 2008 Jan 9.

PMID:
18187297
10.

Assessment of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension.

Selimovic N, Rundqvist B, Bergh CH, Andersson B, Petersson S, Johansson L, Bech-Hanssen O.

J Heart Lung Transplant. 2007 Sep;26(9):927-34.

PMID:
17845932
11.

Echocardiographic and right heart catheterization techniques in patients with pulmonary arterial hypertension.

Celermajer DS, Marwick T.

Int J Cardiol. 2008 Apr 25;125(3):294-303. Epub 2007 Aug 8. Review.

PMID:
17689753
12.

Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension.

White RJ, Meoli DF, Swarthout RF, Kallop DY, Galaria II, Harvey JL, Miller CM, Blaxall BC, Hall CM, Pierce RA, Cool CD, Taubman MB.

Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L583-90. Epub 2007 Jun 22.

14.

Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension.

McMurtry MS, Moudgil R, Hashimoto K, Bonnet S, Michelakis ED, Archer SL.

Am J Physiol Lung Cell Mol Physiol. 2007 Apr;292(4):L872-8. Epub 2006 Dec 1.

15.

Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat.

Hessel MH, Steendijk P, den Adel B, Schutte CI, van der Laarse A.

Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2424-30. Epub 2006 May 26.

16.

Estimation of cardiac output in a pharmacological trial using a simple method based on arterial blood pressure signal waveform: a comparison with pulmonary thermodilution and echocardiographic methods.

Penttilä J, Snapir A, Kentala E, Koskenvuo J, Posti J, Scheinin M, Scheinin H, Kuusela T.

Eur J Clin Pharmacol. 2006 Jun;62(6):401-7. Epub 2006 Mar 29.

PMID:
16570186
17.

Doppler tissue imaging in assessment of pulmonary hypertension-induced right ventricle dysfunction.

Boissiere J, Gautier M, Machet MC, Hanton G, Bonnet P, Eder V.

Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2450-5. Epub 2005 Jul 29.

18.

Pulmonary arterial hypertension: the key role of echocardiography.

Bossone E, Bodini BD, Mazza A, Allegra L.

Chest. 2005 May;127(5):1836-43. Review.

PMID:
15888866
19.

Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure.

Buermans HP, Redout EM, Schiel AE, Musters RJ, Zuidwijk M, Eijk PP, van Hardeveld C, Kasanmoentalib S, Visser FC, Ylstra B, Simonides WS.

Physiol Genomics. 2005 May 11;21(3):314-23. Epub 2005 Feb 22.

20.

New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure.

Chemla D, Castelain V, Humbert M, Hébert JL, Simonneau G, Lecarpentier Y, Hervé P.

Chest. 2004 Oct;126(4):1313-7.

PMID:
15486398
Items per page

Supplemental Content

Write to the Help Desk